APC: Contact APC

Poll: Consumers like you, they really like you (well, those who know about you)
A new national poll gives some telling information about consumers' views on compounding
Semaglutide shortage resolved
Here's what we know so far
Our tirzepatide memo to BoPs
We wrote a simple, 2-page memo for state boards explaining the current legal and regulatory situation around compounding tirzepatide.
State advocacy updates: Feb. 28, 2025
News from Nebraska, Iowa, and Florida
About that Super Bowl ad…
The media has been turning to APC for perspective on the Hims & Hers Super Bowl ad ... a lot.
Once more with monotone: FDA again clarifies discretion on tirzepatide copies
The FDA again clarified its enforcement discretion policy for compounded copies of tirzepatide injections.
State advocacy update: California (again)
In yet another letter to the California Board of Pharmacy, we had to express our serious concerns about proposed compounding regulations.
Another loss for Novo
A federal judge has ruled against Novo Nordisk in a case the company made against a compounding pharmacy.
State advocacy updates: Feb. 14, 2025
Updates on Washington and Louisiana
Good news in the court
A federal court dismissed Novo Nordisk’s lawsuit against Live Well Drugstore — this is good news for a few reasons.

Contact Us

For media inquiries, CLICK HERE.

If you have questions or would like more information about the Alliance for Pharmacy Compounding, our advocacy priorities, or the services we provide, here’s how to contact us.

info@whizkid.com/a4pc

Headquarters

100 Daingerfield Road
Suite 100
Alexandria, VA 22314

Phone: (281) 933-8400
Fax: (281) 495-0602

E-mail: info@whizkid.com/a4pc

About the Alliance

Big buttons

More news

» More APC News «

Contact Us

Headquarters

FOLLOW US @A4PCRX